Biology Matters: Solving Chronic Disease

Fame Host (https://fame.so) Biology Matters: Solving Chronic Disease https://podcasts.fame.so/biology-matters https://feeds.fame.so/biology-matters Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like—and what it will take to make it happen. To find out more about PrecisionLife, visit precisionlife.com and follow @PrecisionLife on LinkedIn. Copyrights © 2026 All Rights Reserved by PrecisionLife en Tue, 26 May 2026 14:44:55 +0000 Wed, 29 Jul 2026 07:50:37 +0000 https://content.fameapp.so/uploads/65qwlx91/5605bfa0-5a8c-11f1-96f0-7da0538cec2a/5605c180-5a8c-11f1-99d4-6f91ffdec983.png Biology Matters: Solving Chronic Disease https://podcasts.fame.so/biology-matters Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like—and what it will take to make it happen. To find out more about PrecisionLife, visit precisionlife.com and follow @PrecisionLife on LinkedIn. PrecisionLife Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like—and what it will take to make it happen. To find out more about PrecisionLife, visit precisionlife.com and follow @PrecisionLife on LinkedIn. No No episodic PrecisionLife Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like—and what it will take to make it happen. To find out more about PrecisionLife, visit precisionlife.com and follow @PrecisionLife on LinkedIn. Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like—and what it will take to make it happen. To find out more about PrecisionLife, visit precisionlife.com and follow @PrecisionLife on LinkedIn. biology matters podcast, chronic disease podcast, precision medicine podcast, healthcare innovation podcast, disease biology podcast, life sciences podcast, biomedical research podcast, future of healthcare podcast, healthcare transformation podcast, medi Steve Gardner team-plf@fame.so No No No Why ME/CFS Has Been Neglected for Decades - And Why That's Finally Changing https://podcasts.fame.so/e/m84l46p8-Sonya-Chowdhury Why ME/CFS Has Been Neglected for Decades - And Why That's Finally Changing 0 No No x16r9ky1 Myalgic encephalomyelitis, also called chronic fatigue syndrome or ME/CFS, affects an estimated 17 – 24 million people worldwide, with many more experiencing ME-like symptoms after infections such as COVID. So, why does the disease remain poorly understood, difficult to diagnose and deeply isolating? In this episode of Biology Matters, host Steve Gardner speaks with Sonya Chowdhury, CEO of Action for ME, about why ME/CFS has remained invisible for so long, how patient advocacy is helping move research, policy and clinical understanding forward and why better funding, better diagnostics and precision medicine could help shift the field from recognition to real treatment options. Myalgic encephalomyelitis, also called chronic fatigue syndrome or ME/CFS, is a serious, life-altering disease that affects an estimated 17 – 24 million people worldwide, with many more living with ME-like symptoms following infections such as COVID. For patients and families, the impact can be enormous: persistent exhaustion, post-exertional malaise, pain, cognitive dysfunction, and in the most severe cases, being housebound, bedbound or unable to manage daily living tasks. And yet, awareness about what it is lags behind, let alone treatment options.

In this episode of Biology Matters, Steve Gardner speaks with Sonya Chowdhury, CEO of Action for ME, about why ME/CFS has remained so under-recognised, despite its scale and severity. Sonya explains that the disease often makes people invisible, because those most affected may be too unwell to leave their homes, attend appointments, work, study or maintain social contact. The conversation explores the importance of advocacy, collaboration and patient involvement in changing that reality.

What You'll Learn:

What ME/CFS is and why post-exertional malaise is such a defining feature of the disease
Why ME/CFS and ME-like symptoms after COVID affect such a large number of people
How invisibility and isolation shape the patient experience
Why advocacy for ME/CFS depends on listening, collaboration and persistence
How patient involvement can make research stronger and more trusted
Why the economic case for better ME/CFS research and care is so significant
How the DecodeME study, LOCOME project, and precision medicine approaches are changing what is possible
Why dedicated funding could accelerate diagnostics, drug repurposing and clinical progress

About Steve

Steve Gardner is CEO and Co-Founder of PrecisionLife, recognized for his expertise in mechanism-based biology and its application to chronic disease management. With over 25 years of experience in life sciences and informatics, he has contributed to the Human Genome Project, led over 30 drug discovery and development initiatives, and built multiple healthcare and AI technologies from concept to market. His work bridging computational biology with clinical translation has positioned him at the forefront of precision medicine for complex chronic conditions.

About Sonya

Sonya Chowdhury is CEO of Action for ME, a UK charity working to improve the lives of children, adults and families affected by myalgic encephalomyelitis, also known as ME or ME/CFS. She works at the intersection of patient advocacy, public policy, research, fundraising and healthcare, helping build understanding of ME and improve recognition of the needs of people living with the disease. Her background in child protection social work has shaped her collaborative approach to advocacy, which is grounded in listening, partnership and championing the rights of people who are facing disadvantage, inequity and injustice. Through Action for ME, Sonya has helped keep patient experience at the centre of research, policy and public awareness, while supporting efforts to improve diagnosis, care, funding and scientific understanding for ME and related post-infectious conditions.

Episode Resources:

Sonya Chowdhury on LinkedIn

Action for ME Website
Steve Gardner on LinkedIn
PrecisionLife Website

Biology Matters is handcrafted by our friends over at: fame.so

]]> Wed, 15 Jul 2026 09:00:00 +0000 PrecisionLife PrecisionLife 3431 Myalgic encephalomyelitis, also called chronic fatigue syndrome or ME/CFS, affects an estimated 17 – 24 million people worldwide, with many more experiencing ME-like symptoms after infections such as COVID. So, why does the disease remain poorly understood, difficult to diagnose and deeply isolating? In this episode of Biology Matters, host Steve Gardner speaks with Sonya Chowdhury, CEO of Action for ME, about why ME/CFS has remained invisible for so long, how patient advocacy is helping move research, policy and clinical understanding forward and why better funding, better diagnostics and precision medicine could help shift the field from recognition to real treatment options. Myalgic encephalomyelitis, also called chronic fatigue syndrome or ME/CFS, affects an estimated 17 – 24 million people worldwide, with many more experiencing ME-like symptoms after infections such as COVID. So, why does the disease remain poorly understood, difficult to diagnose and deeply isolating? In this episode of Biology Matters, host Steve Gardner speaks with Sonya Chowdhury, CEO of Action for ME, about why ME/CFS has remained invisible for so long, how patient advocacy is helping move research, policy and clinical understanding forward and why better funding, better diagnostics and precision medicine could help shift the field from recognition to real treatment options. Myalgic Encephalomyelitis, ME/CFS, Chronic Fatigue Syndrome, Precision Medicine, Long COVID, Post-Exertional Malaise, Chronic Disease Research, Patient Advocacy, ME Research Funding, ME Diagnosis No No How Healthcare Moves from Reactive Care to Preventive with Ray Pawlicki https://podcasts.fame.so/e/5nz74738-ray-pawlicki How Healthcare Moves from Reactive Care to Preventive with Ray Pawlicki 0 No No 80zn6n50 Healthcare systems all around the world are under pressure, and the common denominator is chronic disease. In this episode of Biology Matters, Ray Pawlicki, Executive Chairman at PrecisionLife, and host Steve Gardner explore how a shift from reacting to illness toward diagnosing, treating, and preventing disease much earlier is the solution we need to relieve this pressure. Drawing on decades of leadership experience across Novartis, Biogen, UMass Memorial Health, and beyond, Ray explains why technology is now a strategic priority in healthcare, why culture matters just as much as data, and why solving chronic disease will require new thinking on the part of providers, payers, patients, and healthcare leaders alike. Healthcare systems around the world are facing a difficult reality: more people are living longer, but with multiple chronic diseases that are expensive, difficult to manage, and usually diagnosed too late. In this episode of Biology Matters, Ray Pawlicki, Executive Chairman at PrecisionLife, and host Steve Gardner, unpack why this isn’t just a medical challenge but a technology, leadership, and culture challenge.

What You'll Learn:

The distinct hurdles healthcare faces compared to other industries when adopting technology.
How culture, leadership, and communication shape successful healthcare transformation
Why chronic disease is one of the biggest drivers of healthcare spending and system pressure
Why earlier diagnosis and disease-modifying therapies are essential for long-term health
Where AI can genuinely help healthcare (and where it cannot replace biological understanding)
Why the future of healthcare depends on moving from reactive treatment to precision prevention

About Ray

Ray Pawlicki is Executive Chairman at PrecisionLife and a technology leader with decades of experience across life sciences, healthcare, consumer goods, financial services, and technology. He has held senior leadership roles at organizations including Novartis, Biogen, UMass Memorial Health, PepsiCo, Citibank, and Hewlett Packard.

Over the course of his career, he has worked closely with leadership to make technology and data central to the company’s transformation and lead major culture-change initiatives designed to support more collaborative, science-led, and data-driven ways of working. Today, Ray brings this cross-industry perspective to PrecisionLife, where he focuses on how technology, data, and precision medicine can help healthcare systems diagnose disease earlier, treat patients more effectively, and shift toward prevention.

About Steve

Steve Gardner is CEO and Co-Founder of Precision Life, recognized for his expertise in mechanism-based biology and its application to chronic disease management. With over 25 years of experience in life sciences and informatics, he has contributed to the Human Genome Project, led over 30 drug discovery and development initiatives, and built multiple healthcare and AI technologies from concept to market. His work bridging computational biology with clinical translation has positioned him at the forefront of precision medicine for complex chronic conditions - a space historically overlooked in favor of oncology-focused approaches.

Episode Resources:

Ray Pawlicki on LinkedIn

Steve Gardner on LinkedIn
PrecisionLife Website

Biology Matters is handcrafted by our friends over at: fame.so

]]> Wed, 01 Jul 2026 09:00:00 +0000 PrecisionLife PrecisionLife 2924 Healthcare systems all around the world are under pressure, and the common denominator is chronic disease. In this episode of Biology Matters, Ray Pawlicki, Executive Chairman at PrecisionLife, and host Steve Gardner explore how a shift from reacting to illness toward diagnosing, treating, and preventing disease much earlier is the solution we need to relieve this pressure. Drawing on decades of leadership experience across Novartis, Biogen, UMass Memorial Health, and beyond, Ray explains why technology is now a strategic priority in healthcare, why culture matters just as much as data, and why solving chronic disease will require new thinking on the part of providers, payers, patients, and healthcare leaders alike. Healthcare systems all around the world are under pressure, and the common denominator is chronic disease. In this episode of Biology Matters, Ray Pawlicki, Executive Chairman at PrecisionLife, and host Steve Gardner explore how a shift from reacting to illness toward diagnosing, treating, and preventing disease much earlier is the solution we need to relieve this pressure. Drawing on decades of leadership experience across Novartis, Biogen, UMass Memorial Health, and beyond, Ray explains why technology is now a strategic priority in healthcare, why culture matters just as much as data, and why solving chronic disease will require new thinking on the part of providers, payers, patients, and healthcare leaders alike. Chronic disease, Precision medicine, Preventive healthcare, Early diagnosis, AI in healthcare, Healthcare innovation, Healthcare leadership, Chronic disease management, Personalized medicine, Health technology No No Why Biology Matters: The Future of Precision and Preventive Healthcare https://podcasts.fame.so/e/r874q21n-healthcare-fails-at-chronic-disease Why Biology Matters: The Future of Precision and Preventive Healthcare 0 No No k08yxpr1 Healthcare systems around the world are under growing pressure from aging populations, rising costs, and the increasing burden of chronic disease. In the debut episode of Biology Matters, hosts Steve and Rowan Gardner, co-founders of PrecisionLife, explore why many complex diseases remain so difficult to understand and treat and the merit in answering the question, “How do we prevent people from falling sick? ”. This conversation reveals how advances in biology, data, and precision medicine could help healthcare move toward earlier prediction, more personalized treatment, and better prevention because building healthier futures demands that science, healthcare, and society completely rethink how we understand disease. Healthcare systems around the world are under growing pressure from aging populations, rising costs and the increasing burden of chronic disease. In the debut episode of Biology Matters, hosts Steve and Rowan Gardner, co-founders of PrecisionLife, explore why many complex diseases remain so difficult to understand and treat and the importance of answering the question “How do we prevent people from falling sick?”.

What You'll Learn:

Why the Human Genome Project succeeded in cancer but stalled in chronic disease
How to reframe chronic disease from a market problem to an economic opportunity
The critical infrastructure gap preventing precision medicine deployment in chronic disease
Why political and cultural incentives systematically favor treating symptoms over preventing disease
How leading health systems (UAE, Singapore, integrated US systems) are building competitive advantage through data governance
The immediate opportunity in women's health and rare conditions like ME/CFS and long COVID

Episode Resources:

Steve Gardner on LinkedIn
Rowan Gardner on LinkedIn
PrecisionLife Website

Biology Matters is handcrafted by our friends over at: fame.so

]]> Wed, 17 Jun 2026 09:00:00 +0000 PrecisionLife PrecisionLife 2953 Healthcare systems around the world are under growing pressure from aging populations, rising costs, and the increasing burden of chronic disease. In the debut episode of Biology Matters, hosts Steve and Rowan Gardner, co-founders of PrecisionLife, explore why many complex diseases remain so difficult to understand and treat and the merit in answering the question, “How do we prevent people from falling sick? ”. This conversation reveals how advances in biology, data, and precision medicine could help healthcare move toward earlier prediction, more personalized treatment, and better prevention because building healthier futures demands that science, healthcare, and society completely rethink how we understand disease. Healthcare systems around the world are under growing pressure from aging populations, rising costs, and the increasing burden of chronic disease. In the debut episode of Biology Matters, hosts Steve and Rowan Gardner, co-founders of PrecisionLife, explore why many complex diseases remain so difficult to understand and treat and the merit in answering the question, “How do we prevent people from falling sick? ”. This conversation reveals how advances in biology, data, and precision medicine could help healthcare move toward earlier prediction, more personalized treatment, and better prevention because building healthier futures demands that science, healthcare, and society completely rethink how we understand disease. Precision Medicine, Chronic Disease Prevention, Preventative Healthcare, Personalized Medicine, Healthcare Innovation, Genomics in Healthcare, Mechanism-Based Biology, Chronic Disease Management, Predictive Healthcare, Precision Health SolutionsThat No No Biology Matters Trailer https://podcasts.fame.so/e/286qjyrn-biology-matters-trailer Biology Matters Trailer 0 No No j12r4wv1 Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like - and what it will take to make it happen. Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people and account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. And the result is not just a scientific problem but a system-wide, society-wide healthcare crisis.

Hosted by Steven Gardner and Rowan Gardner of Precision Life, the podcast takes a different approach, starting with biology. Through conversations with healthcare executives, researchers, biotech leaders, and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions.

Each episode connects biological insight to real-world impact, from improving patient outcomes and reducing system inefficiencies to enabling more successful clinical trials and more precise treatment strategies.

If healthcare is to move from reactive treatment when we are sick to predictive, preventive, and personalized care, it will take a fundamental shift in how we understand disease. This podcast is about what that shift looks like and what it will take to make it happen.

Biology Matters is handcrafted by our friends over at: fame.so

]]> Tue, 26 May 2026 17:11:00 +0000 PrecisionLife PrecisionLife 159 Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like - and what it will take to make it happen. Biology Matters is a podcast about one of the biggest challenges facing modern healthcare: chronic disease. These conditions affect billions of people, account for the majority of healthcare spending, and yet remain poorly understood, difficult to diagnose, and often ineffective to treat. The result is not just a scientific problem, but a system-wide healthcare crisis. Hosted by Steve and Rowan Gardner of PrecisionLife, the podcast takes a different approach - starting with biology. Through conversations with healthcare executives, researchers, biotech leaders and patient advocates, Biology Matters explores how a deeper, mechanism-based understanding of disease can transform how we predict risk, stratify patients, and make better clinical and development decisions. Each episode connects biological insight to real-world impact - from improving patient outcomes and reducing system inefficiencies, to enabling more successful clinical trials and more precise treatment strategies. If healthcare is to move from reactive treatment to predictive, preventative, and personalized care, it will require a fundamental shift in how we understand disease. This podcast is about what that shift looks like - and what it will take to make it happen. No No